Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways
Zhongling Zhu(Tianjin Medical University Cancer Institute and Hospital), Yan Zhao(China Association for Science and Technology)
Cited by 17
Related Papers
BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling
|Scientific Reports|2017|32
Anlotinib affects systemic lipid metabolism and induces lipid accumulation in human lung cancer cells
|Lipids in Health and Disease|2023|8